This whitepaper explores how innovative chromatography solutions can improve aggregate removal while maintaining high product purity and yield, reducing both processing time and costs.

These are likely to dominate the future antibody therapeutic market, but many of them express poorly and have aggregation issues leading to delays to projects. Fusion Antibodies utilizes unique ...

The first application-specific module to be added to the new Streamline MP software suite is Refeyn’s Antibody Stability Module, which automatically characterizes aggregation in large batches of ...

Research found that ibrutinib reduces red blood cell aggregation in patients with chronic lymphocytic leukemia (CLL), while ...